Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Biosimilars
Peptides
Proteins
Small molecule therapeutics
Immunotherapy
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Conditions originating in the perinatal period / pediatrics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
External causes of morbidity and mortality / traumatology
Products
In development: 73
On the market: 5
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults, EVENITY a sclerostin inhibitor indicated for the treatment of osteoporosis in postmenopausal women at high...
